CIAS
EW icon

CFS Investment Advisory Services’s Edwards Lifesciences EW Stock Holding History

CFS Investment Advisory Services’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-167,516
Closed -$1K – 318
2022
Q1 		$1K Buy
+167,516
New +$18.8M ﹤0.01% 338

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CFS Investment Advisory Services's EW Position: Q2 2022 in Review

CFS Investment Advisory Services sold out of Edwards Lifesciences (EW) in Q2 2022, closing a stake of 167,516 shares — an estimated $1K sold.

CFS Investment Advisory Services first reported a position in EW in Q1 2022 and held it in 1 quarter. The position peaked at $1K in Q1 2022. 1,272 funds tracked by Wall St. Rank hold EW as of Q2 2022.

  • CFS Investment Advisory Services reported no remaining Edwards Lifesciences position as of Q2 2022 after selling out during the quarter.
  • CFS Investment Advisory Services sold 167,516 Edwards Lifesciences shares in Q2 2022, an estimated $1K.
  • CFS Investment Advisory Services first reported a position in Edwards Lifesciences in Q1 2022 and held it in 1 quarter.
  • CFS Investment Advisory Services's Edwards Lifesciences position peaked at $1K in Q1 2022.
  • 1,272 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2022.

Based on CFS Investment Advisory Services's 13F filing for Q2 2022, filed 16 Aug 2022.